Skip to main content

ORIGINAL RESEARCH article

Front. Oncol. , 09 February 2021

Sec. Pharmacology of Anti-Cancer Drugs

Volume 10 - 2020 | https://doi.org/10.3389/fonc.2020.588533

This article is part of the Research Topic Molecular Mechanisms of Drug Resistance And Strategies of Sensitization in Breast Cancer View all 16 articles

RETRACTED: Emodin Interferes With AKT1-Mediated DNA Damage and Decreases Resistance of Breast Cancer Cells to Doxorubicin

Updated

A retraction of this article was approved in:

  1. Retraction: Emodin interferes with AKT1-mediated DNA damage and decreases resistance of breast cancer cells to doxorubicin

    1. Read retraction

  2. Corrigendum: Emodin Interferes With AKT1-Mediated DNA Damage and Decreases Resistance of Breast Cancer Cells to Doxorubicin

    1. Read correction
Bo Li&#x;Bo Li1†Xin Zhao&#x;Xin Zhao2†Lei ZhangLei Zhang3Wen Cheng*Wen Cheng1*
  • 1Department of Ultrasound, Harbin Medical University Cancer Hospital, Harbin, China
  • 2Department of Orthopedics, The Second Affiliated Hospital of Harbin Medical University, Harbin, China
  • 3Department of Ultrasound, The Second Affiliated Hospital of Harbin Medical University, Harbin, China

This article has been retracted. Please follow the link to the full retraction notice for details.

Citation: Li B, Zhao X, Zhang L and Cheng W (2021) Emodin Interferes With AKT1-Mediated DNA Damage and Decreases Resistance of Breast Cancer Cells to Doxorubicin. Front. Oncol. 10:588533. doi: 10.3389/fonc.2020.588533

Received: 29 July 2020; Accepted: 24 December 2020;
Published: 09 February 2021; Retracted: 07 December 2023.

Edited by:

Jin-Ming Yang, University of Kentucky, United States

Reviewed by:

AHM Khurshid Alam, University of Rajshahi, Bangladesh
Agnieszka Zdzisława Robaszkiewicz, University of Łódź, Poland

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Research integrity at Frontiers

Man ultramarathon runner in the mountains he trains at sunset

94% of researchers rate our articles as excellent or good

Learn more about the work of our research integrity team to safeguard the quality of each article we publish.


Find out more